Ariceum Therapeutics


Ariceum Therapeutics is a privately held radiopharmaceutical firm in the clinical stage that specializes in the detection and targeted treatment of aggressive malignancies, such as neuroendocrine and other hard-to-treat cancers.177Lu-satoreotide tetraxetan (Satoreotide), the company's primary target... Read more

Headquarters

Berlin, Germany

Employees

11-50

Links


Org chart

Manfred Ruediger
CEO of Ariceum Therapeutics GmbH
Collapse
Anika Jäkel
Senior Director
Dennis MEWIS
Head Of Laboratory - CMC & Radiopharmaceutical R&D
Germo Gericke
Chief Medical Officer
Brigitta Voss
Head Program And Portfolio Management
Aaron Block, MBA
Senior Director Business Development
Erwin Bachmohr
Consultant, acting as Head of Procurement & Supply Chain


Offices